Knopp Biosciences is a drug discovery and development company focused on delivering breakthrough treatments in neurological disorders through innovation, experience and partnership. Knopp’s lead compound, KNS-760704, is currently in clinical development for amyotrophic lateral sclerosis, with additional indications under investigation.
Member count: 11-50
Total raised: $17.5M
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Saturn Par... | saturnpart... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 15.12.2014 | - | $5M | - | saturnpart... |
| 25.09.2009 | - | $12.5M | - | medcitynew... |
Mentions in press and media 17
| Date | Title | Description | Category | Author | Source |
| 15.12.2014 | Knopp Bios... | A lot of hopes were pinned on ... | - | - | saturnpart... |
| 14.08.2013 | Foundation... | Pittsburgh’s Knopp Biosciences... | - | - | medcitynew... |
| 12.08.2013 | Knopp Bios... | Canton, MI (August 1, 2013) – ... | - | - | saturnpart... |
| 17.06.2013 | Prize4Life... | CAMBRIDGE, MA. & PITTSBURG... | - | - | saturnpart... |
| 14.11.2012 | Drug devel... | Product: Its lead product is d... | - | - | medcitynew... |
| 13.07.2012 | Biotechnol... | Since it forged a licensing de... | - | - | medcitynew... |
| 06.06.2011 | LaunchCyte... | The latest funding, $1.055 mil... | - | - | medcitynew... |
| 22.06.2010 | LaunchCyte... | By Brandon Glenn Biotechnolog... | - | MedCity Ne... | massdevice... |
| 21.06.2010 | Biotech co... | It’s unclear what plans Launch... | - | - | medcitynew... |
| 25.09.2009 | Pittsburgh... | Promoted Covid-19’s terrible ... | - | - | medcitynew... |
Show more